Hi Huiying

At 2.1A I would be very surprised if you see any density for the H atom
in which case the refinement is not going to move it out of the plane
whatever weight you give the torsion restraint.  To answer your earlier
questions the period of a torsion restraint is the number of energy
minima in a complete rotation of the angle, so the OH bond will have a
period of 2, and
yes the same overall weight is applied to all torsions regardless of the
period, though individual torsions will also be weighted by 1/sd^2.

Cheers

-- Ian 

> -----Original Message-----
> From: [EMAIL PROTECTED] 
> [mailto:[EMAIL PROTECTED] On Behalf Of Huiying Li
> Sent: 04 December 2008 16:35
> To: Abhinav Kumar
> Cc: CCP4BB@JISCMAIL.AC.UK
> Subject: Re: [ccp4bb] tortion angle restraints in REFMAC
> 
> Acturally, I want to find a way to keep the OH tilted out of the 
> neightbouring plane by about 10 degrees. At 2.1A resolution 
> the REFMAC 
> refinement tends to refine it into the plane even though I 
> have included 
> torsion angle restraint in the library for the ligand. I 
> thought I could 
> play with the weight or the esd of the target value but 
> having trouble to 
> achieve it. In CNS, adjusting the force constant of the 
> target value is a 
> way to tighten or loosen the restrain. I would like to know how to 
> "enforce" a geometry effectively in REFMAC.
> 
> Thanks for any comments.
> 
> Huiying
> 
> On Wed, 3 Dec 2008, Abhinav Kumar wrote:
> 
> > If you want to restrain the OH group to a plane, you need 
> to include it in 
> > the plane definition, and not the torsion definition.
> >
> > Thanks Abhinav 
> > Stanford Synchrotron Radiation Laboratory Joint Center for 
> Structural 
> > Genomics Mail Stop 99 Phone: (650) 926-2992 Fax: (650) 926-3292 
> >
> >
> > Huiying Li wrote:
> >> I want to impose restraints during REFMAC refinement on 
> the tortion angles 
> >> that control the tilting of an OH group from a plane in a 
> ligand bound to 
> >> the protein. A few things that confused me:
> >> 
> >> 1. In library cif file, should I just increase or decrease the 
> >> tor.value_angle_esd if I want to loosen or tighten the restraits?
> >> 
> >> 2. What is the meaning of the last column in torsion angle 
> parameters: 
> >> _chem_comp_tor.period, in cif file? In the PDB output file 
> REFMAC also 
> >> lists the RMS and WEIGHT for the torsion angles, period 1 
> through 4.
> >> 
> >> 3. In REFMAC gui under Geometric parameters, there is only 
> one user 
> >> controlled weight for torsion. By changing the weight 
> here, does it change 
> >> the torsion weight for all 4 periods?
> >> 
> >> Thanks in advance for the help.
> >> 
> >> Huiying
> >
> 
> -- 
> Huiying Li, Ph. D
> Department of Molecular Biology and Biochemistry
> Natural Sciences I, Rm 2443
> University of California at Irvine
> Irvine, CA 92697, USA
> Tel: 949-824-4322(or -1953);  Fax: 949-824-3280
> email: [EMAIL PROTECTED]
> 
> 


Disclaimer
This communication is confidential and may contain privileged information 
intended solely for the named addressee(s). It may not be used or disclosed 
except for the purpose for which it has been sent. If you are not the intended 
recipient you must not review, use, disclose, copy, distribute or take any 
action in reliance upon it. If you have received this communication in error, 
please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy 
all copies of the message and any attached documents. 
Astex Therapeutics Ltd monitors, controls and protects all its messaging 
traffic in compliance with its corporate email policy. The Company accepts no 
liability or responsibility for any onward transmission or use of emails and 
attachments having left the Astex Therapeutics domain.  Unless expressly 
stated, opinions in this message are those of the individual sender and not of 
Astex Therapeutics Ltd. The recipient should check this email and any 
attachments for the presence of computer viruses. Astex Therapeutics Ltd 
accepts no liability for damage caused by any virus transmitted by this email. 
E-mail is susceptible to data corruption, interception, unauthorized amendment, 
and tampering, Astex Therapeutics Ltd only send and receive e-mails on the 
basis that the Company is not liable for any such alteration or any 
consequences thereof.
Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, 
Cambridge CB4 0QA under number 3751674

Reply via email to